News and blogs
20 results found.
Does a chemical found in weedkiller cause lymphoma?
For a number of years there has been concern about a potential link between glyphosate (the active ingredient in many weed killers, including RoundUp) and cancer.
EHA annual conference 2020: the promising future of blood cancer research
Here’s a research round-up of all the exciting breakthroughs in blood cancer research discussed at this year’s European Haematology Association conference. From potential new treatments for people with myeloma to understanding more about how blood cancers develop and why they return.
Our view on the proposed ‘pause’ in shielding
What have the UK Governments announced and what are we doing about it?
What effect is COVID-19 having on blood cancer research?
One of the questions I’ve been asked most often since the UK entered lockdown is “what does COVID-19 mean for blood cancer research?”. After two months of lockdown, what have we learned? What does the future hold and what part will Blood Cancer UK play?
New research hope for those with a rare type of leukaemia
Our research fellow, Dr Marc Mansour and his team, have come to understand more about why some types of T-cell acute lymphoblastic leukaemia (T-ALL) stop responding to chemotherapy, and how we might overcome it in the future.
Should children with blood cancer go back to school?
As schools begin to re-open following the coronavirus lockdown, we take a closer look at the issues around children with blood cancer returning to classrooms.
How should coronavirus shielding guidance for blood cancer change?
As we get used to the idea that coronavirus will be with us for a long time, what do we need to know to safely relax shielding guidance? How should that change happen, and how much do we know already?
Common symptoms of coronavirus are also symptoms of blood cancer
Dr Alex Langridge (Haematology Registrar in the North East of England) explains the challenges of detecting blood cancer when symptoms are similar to coronavirus, and what can be done about it.
People with blood cancer now make up a bigger proportion of coronavirus intensive care patients
Our analysis shows the proportion of people in intensive care because of coronavirus – who also have blood cancer – increased between April and May.
Why are people with blood cancer being told to shield for 12 weeks?
While everyone in the UK has felt the impact of the coronavirus over the last few weeks, people with blood cancer have felt it more than most. These 115,000 people have been told not to leave their homes at all for at least 12 weeks, which is called “shielding”.
Meet Alison, our blood cancer clinical nurse specialist
Meet Alison Paterson, a blood cancer clinical nurse specialist and member of our Nurses Working Group. Find out on what it's like working on the front line during the coronavirus pandemic.
Coronavirus mental health crisis for people with blood cancer
Over half of people who are shielding from coronavirus are struggling with their mental health and nearly one in 10 say the impact is severe, our survey of people with blood cancer has found.
How is the coronarvirus affecting the blood cancer community’s mental health?
In the current climate, it’s inevitable that many people’s mental health will be affected to some extent as we’re cooped up inside and cut off from friends and family. But what impact has the coronavirus pandemic had on people affected by blood cancer specifically?
From Dine Out to Dine IN – Confessions of a Technophobe
Technophobe Maria Clarke from our Glasgow and District Branch hosts a successful virtual fundraiser.
Findings from our survey on COVID-19
We surveyed more than 3,000 people affected by blood cancer to find out their concerns about coronavirus. Here's what we found out, and what we're going to do about it.
Over a third of people with blood cancer “haven’t had shielding letter”
Our survey found that over a third of people with blood cancer who are expecting to get a letter telling them to stay at home and shield because of the coronavirus have not yet received one.
People with undiagnosed blood cancer don't know they're vulnerable to coronavirus
There are over 10,000 people with undiagnosed blood cancer who are extremely vulnerable to the coronavirus, but don't know it.
Could a blood cancer drug be used to help people with COVID-19?
Calquence is being trialled in patients with COVID-19 who are critically ill, in the hope that it may reduce damage to their lungs.
Five charities call for supermarkets to sign up to key pledges
We've written to supermarkets with six key pledges, to ensure people with blood cancer and other vulnerable people shielding for 12 weeks can get food deliveries.
Call for supermarkets to prioritise people with blood cancer for online orders
We've written to the government and six major supermarkets, calling on them to take urgent action to make sure people with blood cancer can get food deliveries.
